Jump to Content Jump to Main Navigation

Google Translate

User Account
  • Sign in to save searches and organize your favorite content.
  • Not registered? Create account
  • My Content (0)

    Recently viewed (0)

    • Save Entry
  • My Searches (0)

    Recently viewed (0)

    • Save Search
erc
Menu
  • Home
  • Browse
  • Content
    • Best of 2020
    • Editor's choice
    • Accepted manuscripts
    • Current issue
    • All issues
    • Special issues
  • Submit
    • Author guidelines
    • Submit now
    • Reasons to publish
    • Ethical policy
    • Open access policy
    • Publication charges
    • Author resource centre
  • About
    • Contact the journal
    • Scope
    • Editorial board
    • Societies
    • For libraries
    • Subscribe
    • Abstracting and indexing
  • Alerts
  • Journals
    • Endocrine Connections
    • Endocrine Oncology
    • Endocrinology, Diabetes & Metabolism Case Reports
    • European Journal of Endocrinology
    • Journal of Endocrinology
    • Journal of Molecular Endocrinology
    • Reproduction
    • Reproduction and Fertility
    • Vascular Biology
    • Bone Abstracts
    • Endocrine Abstracts
    • Reproduction Abstracts
    • Bioscientifica Proceedings
Search
Close
Advanced Search Help

Volume 28 (2021): Issue 2 (Feb 2021)

in Endocrine-Related Cancer
Online ISSN:
1479-6821
Print ISSN:
1351-0088
  • Sign up for new article alerts
  • Sign up for eTOC alerts
  • Get Accepted Manuscript Alerts
  • Review
    • Overcoming oncogene addiction in breast and prostate cancers: a comparative mechanistic overview
    • Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
  • Save
  • Collapse
  • Expand
  • Top
Print ISSN:
1351-0088
Online ISSN:
1479-6821
 Society for Endocrinology 75 anniversary logo
  • Sales & advertising
  • Publishing alliances
  • Privacy & cookies
  • Terms and conditions
  • Permissions
  • Help

© 2021 Bioscientifica Ltd

Follow us on: Share Share

Print ISSN: 1351-0088; Online ISSN: 1479-6821    Powered by:

PubFactory
  • [54.236.62.49]
  • 54.236.62.49
Close
Edit

Character limit 500/500

@!

Character limit500/500